|
| CJCP
2015 17 (6):
634-637
ISSN: 1008-8830 CN: 43-1301/R
|
|
|
|
|
|
|
| Efficacy and safety of tyrosine kinase inhibitor dasatinib plus chemotherapy in the treatment of childhood Philadelphia chromosome–positive acute lymphoblastic leukemia |
| GUO Ye, LIU Tian-Feng, YANG Wen-Yu, et al. |
| Diagnostic and Therapeutic Center of Children's Blood Disease, Institute of Hematology, Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin 300020, China. |
| Received: 2014-10-03 Revised: 2014-12-14 Online: null |
Supporting info
|
|
|